Teleflex Publishes 2022 Global Impact Report
15 Maio 2023 - 7:30AM
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies, today announced it has published its 2022
Global Impact Report. The report outlines recent accomplishments
and sets new targets to support the company’s Corporate Social
Responsibility (CSR) program and aligns with the Global Reporting
Initiative (GRI), the Sustainability Accounting Standards Board
(SASB), and Taskforce on Climate-Related Financial Disclosures
(TCFD).
“At Teleflex, we have a business strategy to drive long-term
durable growth. Part of this strategy is to advance corporate
social responsibility and an inclusive culture,” said Liam Kelly,
Chairman, President, and CEO of Teleflex. “The integration of CSR
into our three-year growth strategy strengthens our commitment and
efforts in working towards a more sustainable and inclusive
society.”
“I am excited to announce that Teleflex has just released our
third annual Global Impact Report, which provides information
related to the practical ways we address evolving Environmental,
Social and Governance standards,” said Karen Boylan, Corporate Vice
President, Strategic Projects and Chair of the Corporate Social
Responsibly Steering Committee at Teleflex. “I am extremely proud
of the progress we have made in achieving results and in setting
new measurable goals for the years to come.”
The 2022 Global Impact Report outlines accomplishments and plans
for each of the company’s four CSR pillars: Principals of Ethics
& Governance, Planet & Environment, People, and Prosperity
& Sustainable Healthcare.
Highlights from this year’s report include:
- Setting Science-Based Targets for reducing greenhouse
gases: We committed to setting near-term and long-term net
zero emissions reduction targets for scope 1, 2, and 3 emissions in
2023. In following through with this commitment, Teleflex submitted
its targets to SBTi in April 2023.
- Developing a 3-year roadmap for our DEI
strategy: We have established key parameters that will
govern how we measure progress, inform and educate employees, and
structure our global employee resource groups.
- Continuing our efforts to educate clinicians and
improve access to training: In 2022, we trained over
185,000 healthcare professionals globally and delivered over 475
virtual education programs across 4 regions to over 7000 clinical
customers.
- Rolling out new tools to support ethics
training: We developed new interactive training
modules for our Integrity Policies and Procedures, enabling
training based on the learners’ job responsibilities and their
demonstrated understanding of the material.
Read the full 2022 Global Impact Report at
https://teleflex.com/usa/en/about-us/csr/index.html
About Teleflex IncorporatedTeleflex is a global
provider of medical technologies designed to improve the health and
quality of people’s lives. We apply purpose driven innovation – a
relentless pursuit of identifying unmet clinical needs – to benefit
patients and healthcare providers. Our portfolio is diverse, with
solutions in the fields of vascular access, interventional
cardiology and radiology, anesthesia, emergency medicine, surgical,
urology and respiratory care. Teleflex employees worldwide are
united in the understanding that what we do every day makes a
difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, LMA®, Pilling®,
QuikClot®, Rüsch®, UroLift®, and Weck® – trusted brands united by a
common sense of purpose.
Forward-Looking StatementsAny statements
contained in this press release that do not describe historical
facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which
may cause actual results or company actions to differ materially
from what is expressed or implied by these statements. These risks
and uncertainties are identified and described in more detail in
our filings with the Securities and Exchange Commission, including
our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, LMA, Pilling,
QuikClot, Rüsch, UroLift, and Weck, list all Teleflex-owned
trademarks in alphabetical order] are trademarks or registered
trademarks of Teleflex Incorporated or its affiliates, in the U.S.
and/or other countries.© 2023 Teleflex Incorporated. All rights
reserved.
Contacts:TeleflexLawrence KeuschVice President,
Investor Relations and Strategy Development
investor.relations@teleflex.com610-948-2836
Teleflex (NYSE:TFX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Teleflex (NYSE:TFX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024